Products

What will AGI do for Azanidazole?

This classification denotes an antiprotozoal agent with the molecular formula C10H10N6O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YP2Y0DRX4S, chemically known as 2-pyrimidinamine, 4-(2-(1-methyl-5-nitro-1h-imidazol-2-yl)ethenyl)-, (e)- but generally known as azanidazole, which bears US NIH Compound Identifier 6436171. European Medicines Agency schedules Azanidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05635MIG. The term AZANIDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules azanidazole in its Anatomical Therapeutic Chemical (ATC) Classification. AZANIDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule azanidazole under HS 29335995 and SITC 51576. As of Q4 2014, AZANIDAZOLE remains the US FDA Preferred Term for this commodity. Azanidazole bears US NLM identifiers UMLS ID C0052751 and NCI Concept Code C73274. SMILES: CN1C(=CN=C1/C=C/C2=NC(=NC=C2)N)[N+](=O)[O-].